Key Metrics
Avg P/E Ratio
35.3
Profitable Companies
89%
Avg Growth
89.7%
Avg Dividend Yield
0.52%
Historical Return
1 Year
-3.0%
+0.5% Div
3 Years Ø
-1.0%
+0.5% Div
5 Years Ø
-0.6%
+0.5% Div
1 Year
-1.3%
+0.5% Div
3 Years Ø
-0.1%
+0.5% Div
5 Years Ø
-0.4%
+0.5% Div
Risk & Analysis Metrics
Volatility
51.60%
1 Year
37.62%
3 Years
33.99%
5 Years
258.82%
10 Years
Max Drawdown
-28.19%
1 Year
-30.18%
3 Years
-34.22%
5 Years
-39.33%
10 Years
Sharpe Ratio
0.32
1 Year
0.73
3 Years
0.71
5 Years
0.40
10 Years
Volatility
171.22%
1 Year
234.06%
3 Years
341.60%
5 Years
809.23%
10 Years
Max Drawdown
-12.11%
1 Year
-25.07%
3 Years
-22.51%
5 Years
-51.65%
10 Years
Sharpe Ratio
1.40
1 Year
2.37
3 Years
4.61
5 Years
0.57
10 Years
Return Triangle (Heatmap)
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | -14.2% | -10.2% | -4.6% | -4.1% | -3.7% | -3.3% | -2.7% | -2.4% | -1.6% | -2.6% | -2.5% | -2.7% | -1.7% | -1.2% | 0.1% |
| 2012 | -6.0% | 0.6% | -0.5% | -0.8% | -1.0% | -0.6% | -0.5% | 0.0% | -1.2% | -1.2% | -1.6% | -0.5% | -0.1% | 1.2% | |
| 2013 | 7.6% | 2.4% | 0.9% | 0.3% | 0.5% | 0.4% | 0.9% | -0.6% | -0.7% | -1.1% | 0.0% | 0.4% | 1.7% | ||
| 2014 | -2.6% | -2.2% | -2.0% | -1.2% | -1.0% | -0.1% | -1.7% | -1.7% | -2.0% | -0.8% | -0.3% | 1.3% | |||
| 2015 | -1.9% | -1.6% | -0.7% | -0.6% | 0.4% | -1.5% | -1.5% | -2.0% | -0.6% | 0.0% | 1.6% | ||||
| 2016 | -1.4% | -0.2% | -0.2% | 0.9% | -1.5% | -1.5% | -2.0% | -0.4% | 0.2% | 2.0% | |||||
| 2017 | 1.1% | 0.5% | 1.7% | -1.5% | -1.5% | -2.1% | -0.2% | 0.4% | 2.4% | ||||||
| 2018 | -0.1% | 2.0% | -2.3% | -2.1% | -2.7% | -0.5% | 0.3% | 2.5% | |||||||
| 2019 | 4.3% | -3.4% | -2.8% | -3.3% | -0.5% | 0.3% | 2.9% | ||||||||
| 2020 | -10.6% | -6.1% | -5.7% | -1.7% | -0.4% | 2.7% | |||||||||
| 2021 | -1.5% | -3.2% | 1.5% | 2.3% | 5.6% | ||||||||||
| 2022 | -4.9% | 3.0% | 3.5% | 7.4% | |||||||||||
| 2023 | 11.5% | 8.0% | 11.9% | ||||||||||||
| 2024 | 4.7% | 12.1% | |||||||||||||
| 2025 | 20.0% |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2012 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 2013 | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
| 2014 | - | - | - | - | - | - | - | - | - | - | - | - | |||
| 2015 | - | - | - | - | - | - | - | - | - | - | - | ||||
| 2016 | - | - | - | - | - | - | - | - | - | - | |||||
| 2017 | 0.6% | -2.6% | -1.6% | 47.9% | 35.1% | 25.4% | - | - | - | ||||||
| 2018 | -5.8% | -2.7% | 68.2% | 45.4% | 31.0% | - | - | - | |||||||
| 2019 | 0.4% | 124.7% | 68.0% | 42.3% | - | - | - | ||||||||
| 2020 | 403.0% | 117.4% | 59.8% | - | - | - | |||||||||
| 2021 | -6.0% | -9.9% | - | - | - | ||||||||||
| 2022 | -13.6% | - | - | - | |||||||||||
| 2023 | - | - | - | ||||||||||||
| 2024 | 10.8% | 14.9% | |||||||||||||
| 2025 | 19.1% |
Distributions
Last updated: Oct 15, 2026Profit Margin Distribution
P/E Ratio Distribution
Discounted Cash Flow
Weighted Average Undervaluation
N/A
Undervalued
Overvalued
Equal Weight Average Undervaluation
N/A
Undervalued
Overvalued
Portfolio Concentration
46.3%
Top 5 Holdings
56.7%
Top 10 Holdings
81.9%
Top 50 Holdings
89.8%
Top 100 Holdings
Top 5 Companies
Market Cap Size Distribution
Micro: < $300M
Small: $300Mā$2B
Mid: $2Bā$10B
Large: $10Bā$200B
Mega: > $200B
Micro: < $300M
Small: $300Mā$2B
Mid: $2Bā$10B
Large: $10Bā$200B
Mega: > $200B
Latest News
View all news →
3 days ago
• marketbeat.com
Sartorius Aktiengesellschaft Q3 Earnings Call Highlights
Sartorius Aktiengesellschaft ETR: SRT reported solid growth, improved profitability and stronger cash generation for the first nine months of 2026,...
3 days ago
• newsfilecorp.com
Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (BBNX) Investors: Securities Class Action Deadline is November 3, 2026
New York, New York--(Newsfile Corp. - October 22, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against ...
3 days ago
• defenseworld.net
Head-To-Head Review: ICU Medical (NASDAQ:ICUI) & Beta Bionics (NASDAQ:BBNX)
Beta Bionics (NASDAQ: BBNX - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both healthcare companies, but which is the supe...
Average metrics of all companies in sector Last updated: Oct 25, 2026
Compare to Market
| Market Cap The average market value of companies in this sector. | $2.38T | |
| Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. | 0.52 % | |
| Beta Indicates the relationship between the price performance of a share and the market. | 0.47 | |
| P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. | 35.32 | |
| Negative P/E Ratio A negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything. | -46.38 | |
| Profitable Companies | 89% | |
| PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. | 12.73 | |
| Price to Sales Ratio Market cap divided by the revenue in the most recent year. | 20.31 | |
| Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company. | 6.5 |
Compare to Market
| Enterprise Value to EBIT Enterprise Value divided by EBIT. | 24.62 | |
| Enterprise Value to Revenue Enterprise value divided by revenue. | 13.76 | |
| Total Debt to Enterprise Value Total debt divided by enterprise value. | 0.09 | |
| Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. | 0.29 | |
| Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. | 10.20% | |
| Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. | +89.7% | |
| Return on Equity Equity divided by market cap. | 9.13% | |
| Return on Assets Indicates a company's profitability in relation to its total assets. | 6.94% | |
| Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. | 10.81% |
Stock Screener
Select filters to narrow down the 4126 companies below
4126 companies
Market Cap
$159.11T
Dividends
0.0%
P/E Ratio
-420.8
Revenue
$657B
Net Income
-$154B
Profit Margin
-23.4%
Employees
4.84K
View Stock
Market Cap
$68.25T
Dividends
0.0%
P/E Ratio
37.7
Revenue
$1.49T
-10.2%
Net Income
$391B
-31.9%
Profit Margin
+26.2%
Employees
5.46K
View Stock
Market Cap
$44.34T
Dividends
0.4%
P/E Ratio
28.1
Revenue
$1.39T
Net Income
$371B
Profit Margin
+26.6%
Employees
3.15K
View Stock
Market Cap
$24.74T
Dividends
0.0%
P/E Ratio
20.0
Revenue
$3.49T
Net Income
$301B
Profit Margin
+8.6%
Employees
14.72K
View Stock
Market Cap
$24.27T
Dividends
2.5%
P/E Ratio
17.2
Revenue
$1.41T
Net Income
$358B
Profit Margin
+25.4%
Employees
9.3K
View Stock
Market Cap
$16.94T
Dividends
5.4%
P/E Ratio
24.8
Revenue
$2.73T
Net Income
$183B
Profit Margin
+6.7%
Employees
2.33K
View Stock
Market Cap
$15.63T
Dividends
0.2%
P/E Ratio
71.3
Revenue
$68.9B
Net Income
$28.4B
Profit Margin
+41.2%
Employees
161
View Stock
Market Cap
$12.3T
Dividends
0.0%
P/E Ratio
2049.9
Revenue
$91.2B
Net Income
$2.17B
Profit Margin
+2.4%
Employees
866
View Stock
Market Cap
$11.86T
Dividends
5.7%
P/E Ratio
8.0
Revenue
$3.7T
Net Income
$423B
Profit Margin
+11.4%
Employees
4.39K
View Stock
Market Cap
$11.86T
Dividends
5.7%
P/E Ratio
8.0
Revenue
$3.7T
Net Income
$423B
Profit Margin
+11.4%
Employees
4.39K
View Stock
Market Cap
$11.18T
Dividends
3.1%
P/E Ratio
23.7
Revenue
$339B
Net Income
$115B
Profit Margin
+34.1%
Employees
5.1K
View Stock
Market Cap
$11.18T
Dividends
3.1%
P/E Ratio
23.7
Revenue
$339B
Net Income
$115B
Profit Margin
+34.1%
Employees
5.1K
View Stock
Market Cap
$11.18T
Dividends
3.1%
P/E Ratio
23.7
Revenue
$339B
Net Income
$115B
Profit Margin
+34.1%
Employees
5.1K
View Stock
Market Cap
$10.61T
Dividends
0.0%
P/E Ratio
57.4
Revenue
$746B
Net Income
$37.3B
Profit Margin
+5.0%
Employees
7.35K
View Stock
Market Cap
$10.42T
Dividends
10.5%
P/E Ratio
10.8
Revenue
$826B
Net Income
$186B
Profit Margin
+22.6%
Employees
3.56K
View Stock
Market Cap
$8.25T
Dividends
0.0%
P/E Ratio
94.5
Revenue
$301M
Net Income
$65.9M
Profit Margin
+21.9%
Employees
9
View Stock
Market Cap
$7.7T
Dividends
2.7%
P/E Ratio
19.5
Revenue
$1.83T
Net Income
$91.9B
Profit Margin
+5.0%
Employees
19.24K
View Stock
Market Cap
$6.54T
Dividends
1.4%
P/E Ratio
16.2
Revenue
$711B
Net Income
$119B
Profit Margin
+16.7%
Employees
37.76K
View Stock
Market Cap
$6.54T
Dividends
1.4%
P/E Ratio
16.2
Revenue
$711B
Net Income
$119B
Profit Margin
+16.7%
Employees
37.76K
View Stock
Market Cap
$6.54T
Dividends
1.4%
P/E Ratio
16.2
Revenue
$711B
Net Income
$119B
Profit Margin
+16.7%
Employees
37.76K
View Stock